168 related articles for article (PubMed ID: 11438744)
1. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.
Kim MM; Rivera MA; Botchkina IL; Shalaby R; Thor AD; Blackburn EH
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7982-7. PubMed ID: 11438744
[TBL] [Abstract][Full Text] [Related]
2. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
Li S; Rosenberg JE; Donjacour AA; Botchkina IL; Hom YK; Cunha GR; Blackburn EH
Cancer Res; 2004 Jul; 64(14):4833-40. PubMed ID: 15256453
[TBL] [Abstract][Full Text] [Related]
3. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
Goldkorn A; Blackburn EH
Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
[TBL] [Abstract][Full Text] [Related]
4. Growth defects in mouse telomerase RNA-deficient cells expressing a template-mutated mouse telomerase RNA.
Marie-Egyptienne DT; Brault ME; Nimmo GA; Londoño-Vallejo JA; Autexier C
Cancer Lett; 2009 Mar; 275(2):266-76. PubMed ID: 19056167
[TBL] [Abstract][Full Text] [Related]
5. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
6. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of telomerase limits the growth of human cancer cells.
Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
[TBL] [Abstract][Full Text] [Related]
8. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability.
Guiducci C; Cerone MA; Bacchetti S
Oncogene; 2001 Feb; 20(6):714-25. PubMed ID: 11314005
[TBL] [Abstract][Full Text] [Related]
9. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines.
Naka K; Yokozaki H; Yasui W; Tahara H; Tahara E; Tahara E
Biochem Biophys Res Commun; 1999 Feb; 255(3):753-8. PubMed ID: 10049783
[TBL] [Abstract][Full Text] [Related]
10. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.
Sallinen P; Miettinen H; Sallinen SL; Haapasalo H; Helin H; Kononen J
Am J Pathol; 1997 Apr; 150(4):1159-64. PubMed ID: 9094971
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
[TBL] [Abstract][Full Text] [Related]
14. Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
Fajkus J; Borsky M; Kunická Z; Kovaríková M; Dvoráková D; Hofmanová J; Kozubík A
Anticancer Res; 2003; 23(2B):1605-12. PubMed ID: 12820429
[TBL] [Abstract][Full Text] [Related]
15. Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.
Zhang X; Chen Z; Chen Y; Tong T
Oncogene; 2003 Apr; 22(16):2405-16. PubMed ID: 12717417
[TBL] [Abstract][Full Text] [Related]
16. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
[TBL] [Abstract][Full Text] [Related]
19. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
20. Expression of a recombinant vector of a mutant human telomerase reverse transcriptase gene in human bladder cancer cell line T24, and its clinical significance.
Fu WJ; Hong BF; Huang JJ; Xu B; Gao JP; Wang XX; Huang CF
BJU Int; 2005 Oct; 96(6):890-4. PubMed ID: 16153224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
